Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I will double my holding if this reaches 6.5. Orders are in but not looking good.
It would seem something positive is on the way....
Holding green today. Stout!
No gonna lie. Your pickup at 2 on RSOL was impressive. I see a lot if similarities here less the consolidation. I hope I can get in at 2, but I will watch this closely for a higher entry.
What do you think, double down at $2 and hold on for the ride? How'd you do on rsol?
And that is fantastic
No news!! Fantastic!
7.75 on the way!
People are waking up to the rumor.. Volume looking good!
ARIA must report offers. Expect news in the AM and the fun really starts!
Look at volume, brother. Alot of folks will wake up to this news!
Could go higher and over a longer period of time. Buyouts create extended interest driving prices sky high. We are less than half prior levels and primed for a move without the news. It's champaign tonight for your boy!
Did I read the price they are willing to pay correctly????!!!!
$20/ share
:O
That was fast! up 5% afterhours. Weeee!
With current Accum/Dist bottoming out.
Interesting story on the MACD....
Gap tomorrow we can drive a bus through!
I believe you are right, Azy. The December move was 4days....
We have a great chance of a 25mil volume day. $8 has a high probability early. Long is the way here, huge gap to fill!
News~ Here's your spark...
Biologics Selected by ARIAD to Be the Exclusive Specialty Pharmacy Provider for Iclusig (ponatinib)
Font size: A | A | A
7:29 AM ET 1/13/14 | BusinessWire
Biologics, Inc., an integrated oncology services company, is pleased to announce that it has been selected by ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) to be the sole specialty pharmacy provider of Iclusig(R) (ponatinib) and manager of its Patient Access and Support Services (ARIAD PASS(TM)) program. Iclusig is a treatment for adult patients with refractory chronic myeloid leukemia or Philadelphia-chromosome positive (Ph+) acute lymphoblastic leukemia.
The decision by ARIAD to utilize a closed distribution network with Biologics was made to ensure a high-touch care model for patients on Iclusig and to increase efficiencies as the product is made commercially available in the U.S. this month.
"We believe Biologics' approach to patient care and expertise within oncology will deliver the best value and experience to our patients and providers," said Marty J. Duvall, executive vice president and chief commercial officer at ARIAD. "Our primary objective is to make sure that our patients can access, afford and adhere to this important cancer medicine."
In addition to providing pharmacy services and supporting the ARIAD PASS program, Biologics will help transition patients from the Iclusig single-patient Investigational New Drug (sIND) program to commercial or patient assistance product offerings. Biologics will also manage ARIAD's patient assistance and co-pay support programs by conducting benefits investigations and prior authorizations to assess and assist with patient eligibility.
"We're thrilled to be selected by ARIAD as the exclusive integrated channel partner for Iclusig," said Dan Duffy, chief business development officer at Biologics. "We share the same goal of making sure patients receive the best care on Iclusig and are dedicated to providing seamless execution."
Iclusig will be available commercially in the U.S. this month. For more information on Iclusig, please visit www.iclusig.com. For more information on the ARIAD PASS program, patients and physicians should call the U.S. toll-free phone number 1-855-447-PASS (7277).
I covered most Friday. Will premarket if necessary. Who bought those 7.29's premarket Friday? You owe me some skivies!
Nice consolidation after the spike.. I think we have another run on our hands. Good news from the shareholders meeting would help.
Lol! I sold 16k at the resistance. Looks like I will be chasing now..... Oh well, can't complain with winners!
Banging the resistance! 2.79 breaks, were in for a real ride..
We are seeing a slow climb in solar plays over the holiday. 2.61 should fall relatively easy. 2.79 is key.
Interesting action today....
I bet we find a mild support at 2.41 here.
Nice buy at $2! I filled $2.21
There is a gap to fill, up to $3.4 or so!
Any ideas on the premarket bullrush?
Are you referring to Mercury?
We are pinching. Golden cross coming soon
I anticipate a PR summarizing the events of today's meeting. Could be the catalyst needed to start us off.
I expect a PR summarizing today's meeting. It could be the catalyst needed to kick off the next leg up.
And nobody want to sell any to me...
I have a little over 1.3 sitting on bid at 7. Would be happy to bump up with incresed support.
Anyone want out at 7? Load me up!
Any weak hands this morning wanna fill me up?!
By the look of this chart we are gonna get B slapped by volume soon!
Glad I've been accumulating! Ready to see why?